Back to search

Article

The impact of National Centralized Drug Procurement policy on the use of policy-related original and generic drugs in public medical institutions in China: A difference-in-difference analysis based on national database

2021-06-28

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objective</h4> To evaluate the impact of the first round of the National Centralized Drug Procurement (NCDP) pilot (referred to as “4+7” policy) on the use of policy-related original and generic drugs. <h4>Methods</h4> Drug purchase data from the China Drug Supply Information Platform (CDSIP) database were used, involving nine “4+7” pilot cities and 12 non-pilot provinces in China. “4+7” poli...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8b4c72bc-ac6f-51d9-a28f-5e780e30c61d
DOI
10.1101/2021.06.21.21256568
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The impact of National Centralized Drug Procurement policy on the use of policy-related original and generic drugs in public medical institutions in China: A difference-in-difference analysis based on national databaseDOI 10.1101/2021.06.21.21256568
The impact of the national centralized drug procurement on the use of original and generic targeted anti- tumor drugs in Hohhot, China: an interrupted time-series analysisSemantic proximity
Availability, Prices and Affordability of Nationally Negotiated Antidiabetic Drugs in China: A National SurveySemantic proximity
Effects of volume-based procurement policy on the usage and expenditure of first-generation targeted drugs for non-small cell lung cancer with EGFR mutation in China: an interrupted time series study.Semantic proximity
Patients' Attitudes towards Switching to National Volume-Based Procurement (NVBP) Drugs -A Qualitative Investigation in Wuhan, ChinaSemantic proximity
A Study on the Heterogeneous Effects of China’s Volume- Based Procurement on Gastrointestinal and Metabolic MedicationsSemantic proximity
Access to Essential and Innovative Anti-cancer Medicines: A Longitudinal Study in Nanjing, ChinaSemantic proximity
Use of real-world evidence in regulatory decisions for traditional Chinese medicine---Current status and futureSemantic proximity
Prescription volume and costs of over-the-counter–like drugs in Japan by patient and healthcare facility characteristics: A nationwide descriptive studySemantic proximity
Deregulation and pricing of medical services: A policy experiment based in ChinaSemantic proximity
Study on the Effect of Implementing the National Essential Medicine System in a Tertiary Hospital in Zunyi City, Guizhou ProvinceSemantic proximity
Risk Assessment and Management of Drug Inventory in Hospitals during COVID-19 Pandemic in TaiwanSemantic proximity
What Factors Hindered the Access to Essential Anti-Cancer Medicine in Public Hospitals amongst the Local Population in Hubei Province, China?Semantic proximity
Select a neighboring publication to make it the new centre.